Active substances
Diphtheria + Pertussis + Tetanus
- SFDA 8
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| D.T.COQ/D.T.P. VACCINE | 30, 60, 4 IU | Suspension · Intramuscular use | 10 Vial | SAR 110.25 | Biological · Prescription | SANOFI PASTEUR | Withdrawn by MAH · Not Marketed |
| D.T.Coq VACCINE | Suspension for injection · Intramuscular use | 20 Ampoule | SAR 69.00 | Biological · Prescription | SANOFI PASTEUR | Withdrawn by MAH · Not Marketed | |
| INFANRIX 0.5ML PREFILLED SYRINGE | Suspension for injection · Intramuscular use | 1 Injection Syringe | SAR 67.35 | Biological · Prescription | GLAXO SAUDI ARABIA | Withdrawn by MAH · Not Marketed | |
| INFANRIX 0.5ML PREFILLED SYRINGE | Suspension for injection · Intramuscular use | 1 Injection Syringe | SAR 67.35 | Biological · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed | |
| INFANRIX-HIB 0.5 ML SYRINGE | Powder and suspension for suspension for injection · Intramuscular use | 1 Injection Syringe | SAR 108.65 | Biological · Prescription | GLAXO SAUDI ARABIA | Withdrawn by MAH · Not Marketed | |
| INFANRIX-HIB 0.5 ML SYRINGE | Powder and suspension for suspension for injection · Intramuscular use | 1 Injection Syringe | SAR 108.65 | Biological · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed | |
| TETRAMUNE VACCINE | Solution for injection · Intramuscular use | 1 Vial | SAR 632.70 | Biological · Prescription | WYETH | Withdrawn by MAH · Not Marketed | |
| TRITANRIX-HB 10ug-ML 0.5ML VIAL | Solution · Intramuscular use | 1 Vial | SAR 42.65 | Biological · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.